HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer

被引：0
|
作者：
François Cherifi
Angélique Da Silva
Alison Johnson
Cécile Blanc-Fournier
Olivia Abramovici
Antonin Broyelle
Christelle Levy
Djelila Allouache
Ioana Hrab
Carine Segura
Adeline Morel
Maud Villemin
Clémence Boscher
Coraline Dubot-Poitelon
Pauline Rottier
Justine Lequesne
George Emile
机构：
[1] CLCC Francois Baclesse,Department of Clinical Research
[2] CLCC François Baclesse,Breast Cancer Unit
[3] Institut Normand du Sein,Department of Pathology
[4] CLCC Francois Baclesse,Department of Pathology
[5] CLCC Oscar Lambret,Breast Cancer Unit
[6] CLCC Oscar Lambret,undefined
来源：
BMC Cancer | / 22卷
关键词：
Antibody–drug conjugates; HER2-low; Breast cancer; Trastuzumab–deruxtecan; Neoadjuvant treatment; Lymphocytes; Neutrophils;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer
    Cherifi, Francois
    Da Silva, Angelique
    Johnson, Alison
    Blanc-Fournier, Cecile
    Abramovici, Olivia
    Broyelle, Antonin
    Levy, Christelle
    Allouache, Djelila
    Hrab, Ioana
    Segura, Carine
    Morel, Adeline
    Villemin, Maud
    Boscher, Clemence
    Dubot-Poitelon, Coraline
    Rottier, Pauline
    Lequesne, Justine
    Emile, George
    BMC CANCER, 2022, 22 (01)
  • [2] Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy
    Shao, Yingbo
    Guan, Huijuan
    Luo, Zhifen
    Yu, Yang
    He, Yaning
    Chen, Qi
    Liu, Chaojun
    Zhu, Fangyuan
    Liu, Hui
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [3] Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
    Ilie, Silvia Mihaela
    Briot, Nathalie
    Constantin, Guillaume
    Roussot, Nicolas
    Ilie, Alis
    Bergeron, Anthony
    Arnould, Laurent
    Beltjens, Francoise
    Desmoulin, Isabelle
    Mayeur, Didier
    Kaderbhai, Coureche
    Hennequin, Audrey
    Jankowski, Clementine
    Padeano, Marie Martine
    Costaz, Helene
    Amet, Alix
    Coutant, Charles
    Coudert, Bruno
    Bertaut, Aurelie
    Ladoire, Sylvain
    BREAST CANCER, 2023, 30 (06) : 997 - 1007
  • [4] Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
    Silvia Mihaela Ilie
    Nathalie Briot
    Guillaume Constantin
    Nicolas Roussot
    Alis Ilie
    Anthony Bergeron
    Laurent Arnould
    Françoise Beltjens
    Isabelle Desmoulin
    Didier Mayeur
    Courèche Kaderbhai
    Audrey Hennequin
    Clémentine Jankowski
    Marie Martine Padeano
    Helène Costaz
    Alix Amet
    Charles Coutant
    Bruno Coudert
    Aurélie Bertaut
    Sylvain Ladoire
    Breast Cancer, 2023, 30 : 997 - 1007
  • [5] The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
    Wang, Wei
    Zhu, Tingting
    Chen, Hao
    Yao, Yongzhong
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06) : 1673 - 1681
  • [6] The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
    Wei Wang
    Tingting Zhu
    Hao Chen
    Yongzhong Yao
    Clinical and Translational Oncology, 2023, 25 : 1673 - 1681
  • [7] HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study
    Baez-Navarro, Ximena
    van Bockstal, Mieke R.
    Jager, Agnes
    van Deurzen, Carolien H. M.
    PATHOLOGY, 2024, 56 (03) : 334 - 342
  • [8] Pathological complete response and prognosis after neoadjuvant chemotherapy in patients with HER2-low breast cancer
    Qiao, Weiqiang
    Guo, Wanying
    Liu, Qipeng
    Guo, Xiao
    Deng, Miao
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 64
  • [9] Analyzing Neoadjuvant Chemotherapy Effects in HER2-Low Breast Cancer: Real World Data
    Antonini, Marcelo
    Mattar, Andre
    Richter, Fernanda G.
    Ramos, Marcellus N.
    Teixeira, Marina D.
    Pantarotto, Nathalia N.
    Matta, Nadia F.
    Amorim, Andressa G.
    Pinheiro, Denise J.
    Lopes, Reginaldo C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [10] HER2 as a predictive factor for successful neoadjuvant anthracycline chemotherapy of locally advanced and early breast cancer
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Li, Qing
    Zhang, Pin
    Cai, Ruigang
    Ma, Fei
    Fan, Ying
    Luo, Yang
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (03) : E187 - E192
12345